Cargando…
Linking market authorizations of medicines with disease burden in South Africa
BACKGROUND: Sub-Saharan Africa is going through an epidemiological transition, including an impressive increase in non-communicable diseases. The introduction of medicines has not kept pace with the needs in developing countries. The objectives of this study were to (i) examine the correlation betwe...
Autores principales: | Narsai, K., Leufkens, H. G. M., Mantel-Teeuwisse, A. K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017838/ https://www.ncbi.nlm.nih.gov/pubmed/33795015 http://dx.doi.org/10.1186/s40545-021-00314-x |
Ejemplares similares
-
Impact of regulatory requirements on medicine registration in African countries – perceptions and experiences of pharmaceutical companies in South Africa
por: Narsai, Kirti, et al.
Publicado: (2012) -
Variability in market uptake of psychotropic medications in Europe reflects cultural diversity
por: Hoebert, J. M., et al.
Publicado: (2017) -
Selection of essential medicines for the prevention and treatment of cardiovascular diseases in low and middle income countries
por: Bazargani, Y. T., et al.
Publicado: (2018) -
Selection of Essential Medicines for Diabetes in Low and Middle Income Countries: A Survey of 32 National Essential Medicines Lists
por: Bazargani, Yaser T., et al.
Publicado: (2014) -
Post‐marketing dosing changes in the label of biologicals
por: Minnema, Lotte A., et al.
Publicado: (2019)